A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease
Clinical trial NCT06248619 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06248619
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-05
- Primary completion
- 2025-12-23
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.